CIK 0001649989
- Non-accelerated filer
- Smaller reporting company
Outlook Therapeutics, Inc.
Sign in to watch- Ticker
- OTLK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 383982704
- Phone
- +1 609-619-3990
- Business address
- 111 S. WOOD AVENUE, UNIT #100, ISELIN, NJ, 08830
- Former names
- Oncobiologics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 71 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-03 | Syntone Ventures LLC 10% owner | Purchase | +3,000,000 | $1.00 | $3.0M | 19,823,045 |
| 2021-02-02 | Sukhtian Ghiath M. Director | Purchase | +8,360,000 | $1.00 | $8.4M | 10,820,630 |
| 2020-10-05 | Haddadin Yezan Munther Director | Grant or award · Stock Option (Right to Buy) | +160,474 | $0.51 | $82K | 160,474 |
| 2020-10-05 | Sukhtian Faisal Ghiath Director | Grant or award · Stock Option (Right to Buy) | +151,721 | $0.51 | $78K | 151,721 |
| 2020-10-05 | Huang Andong Director | Grant or award · Stock Option (Right to Buy) | +77,805 | $0.51 | $40K | 77,805 |
| 2020-10-05 | THURMAN RANDY H Director | Grant or award · Stock Option (Right to Buy) | +396,809 | $0.51 | $204K | 396,809 |
| 2020-10-05 | Auffarth Gerd Director | Grant or award · Stock Option (Right to Buy) | +85,586 | $0.51 | $44K | 85,586 |
| 2020-10-05 | HILZINGER KURT J Director | Grant or award · Stock Option (Right to Buy) | +116,708 | $0.51 | $60K | 116,708 |
| 2020-10-05 | Gangolli Julian S Director | Grant or award · Stock Option (Right to Buy) | +150,748 | $0.51 | $77K | 150,748 |
| 2020-10-01 | KENYON LAWRENCE A CEO, Pres, CFO, Treas & Secy | Grant or award · Stock Option (Right to Buy) | +3,668,984 | 3,668,984 | ||
| 2020-10-01 | Haddadin Yezan Munther Director | Grant or award · Stock Option (Right to Buy) | +290,372 | 290,372 | ||
| 2020-10-01 | Sukhtian Faisal Ghiath Director | Grant or award · Stock Option (Right to Buy) | +296,352 | 296,352 | ||
| 2020-10-01 | THURMAN RANDY H Director | Grant or award · Stock Option (Right to Buy) | +259,297 | 259,297 | ||
| 2020-10-01 | HILZINGER KURT J Director | Grant or award · Stock Option (Right to Buy) | +217,602 | 217,602 | ||
| 2020-09-22 | Haddadin Yezan Munther Director | Purchase | +10,000 | $0.72 | $7K | 10,000 |
| 2020-09-17 | Sukhtian Faisal Ghiath Director | Purchase | +10,000 | $0.67 | $7K | 10,000 |
| 2020-09-14 | THURMAN RANDY H Director | Purchase | +10,000 | $0.62 | $6K | 11,875 |
| 2020-07-17 | THURMAN RANDY H Director | Grant or award · Stock Option (Right to Buy) | +154,555 | 154,555 | ||
| 2020-07-17 | THURMAN RANDY H Director | Grant or award · Stock Option (Right to Buy) | +210,000 | 210,000 | ||
| 2020-07-17 | Sukhtian Faisal Ghiath Director | Grant or award · Stock Option (Right to Buy) | +135,000 | 135,000 |
Page 10 of 14 · 276 trades